(Q93851853)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

title

The causality of depression in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

The Causality of Depression in Schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

12 August 2023

1 reference

J. Galdi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6136307

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6136307

12 August 2023

publication date

1 June 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

10 May 2020

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000116228

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

British Journal of Psychiatry

12 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

page(s)

621-624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

Depressive States Occurring During the Neuroleptic Treatment of Schizophrenia

10 May 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Depressive states during the clinical treatment of 280 schizophrenic inpatients (author's transl)

12 August 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

'Revealed' Depression and Drug Treatment for Schizophrenia

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Depressive States Occurring During the Neuroleptic Treatment of Schizophrenia

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

An investigation of the postpsychotic depressive syndrome

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Postpsychotic depression in schizophrenia

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Studies of depressive symptoms in schizophrenia

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

12 August 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

'Revealed' Depression and Drug Treatment for Schizophrenia

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Drug-Induced Mood Disorders

12 August 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Depression 'revealed' in schizophrenia

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Depression 'revealed' in schizophrenia

12 August 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study

12 August 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study

12 August 2023

20

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Lithium treatment in post-psychotic depression

12 August 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate

12 August 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

Studies of depressive symptoms in schizophrenia

12 August 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.142.6.621

12 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6136307%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

1 reference